PATTERNS OF EXPRESSION OF THE P53 TUMOR SUPPRESSOR IN HUMAN BREAST TISSUES AND TUMORS INSITU AND INVITRO

被引:334
作者
BARTEK, J [1 ]
BARTKOVA, J [1 ]
VOJTESEK, B [1 ]
STASKOVA, Z [1 ]
REJTHAR, A [1 ]
KOVARIK, J [1 ]
LANE, DP [1 ]
机构
[1] IMPERIAL CANC RES FUND, CLARE HALL LABS, POTTERS BAR EN6 3LD, HERTS, ENGLAND
关键词
D O I
10.1002/ijc.2910460515
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An extensive series of histological sections reflecting the various states of normal breast tissue, and a range of benign and malignant lesions, were examined for the expression of the p53 protein using a panel of anti‐p53 antibodies. In 2 separate series the results of using frozen or methacarn‐fixed, paraffin‐embedded sections were compared. Strong positive staining for p53 was detected in over 50% of the malignant lesions when frozen sections were used. This number fell to just over 20% when methacarn‐fixed sections were examined. In neither series was any p53 staining seen in normal breast or in the benign lesions. Studies by Western blotting on breast cell lines confirmed that this histological signal is due to a pronounced over‐expression of the p53 protein. Earlier studies show that this over‐expression is associated with mutation of the p53 gene. Mutation of the p53 gene with over‐expression of the mutant protein is therefore one of the most frequent specific genetic changes in malignant breast cancer. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:839 / 844
页数:6
相关论文
共 20 条
  • [1] IMMUNOLOGICALLY DISTINCT P53 MOLECULES GENERATED BY ALTERNATIVE SPLICING
    ARAI, N
    NOMURA, D
    YOKOTA, K
    WOLF, D
    BRILL, E
    SHOHAT, O
    ROTTER, V
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (09) : 3232 - 3239
  • [2] CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS
    BAKER, SJ
    FEARON, ER
    NIGRO, JM
    HAMILTON, SR
    PREISINGER, AC
    JESSUP, JM
    VANTUINEN, P
    LEDBETTER, DH
    BARKER, DF
    NAKAMURA, Y
    WHITE, R
    VOGELSTEIN, B
    [J]. SCIENCE, 1989, 244 (4901) : 217 - 221
  • [3] ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION
    BANKS, L
    MATLASHEWSKI, G
    CRAWFORD, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03): : 529 - 534
  • [4] BARTEK J, 1990, ONCOGENE, V5, P893
  • [5] BARTEK J, 1985, J CELL SCI, V75, P17
  • [6] P53 EXPRESSION IN BREAST-CANCER
    CATTORETTI, G
    RILKE, F
    ANDREOLA, S
    DAMATO, L
    DELIA, D
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) : 178 - 183
  • [7] Crawford L V, 1984, Mol Biol Med, V2, P261
  • [8] DURBAN EM, 1986, BREAST CANCER ORIGIN
  • [9] ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE
    FINLAY, CA
    HINDS, PW
    TAN, TH
    ELIYAHU, D
    OREN, M
    LEVINE, AJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) : 531 - 539
  • [10] ACTIVATING MUTATIONS IN P53 PRODUCE A COMMON CONFORMATIONAL EFFECT - A MONOCLONAL-ANTIBODY SPECIFIC FOR THE MUTANT FORM
    GANNON, JV
    GREAVES, R
    IGGO, R
    LANE, DP
    [J]. EMBO JOURNAL, 1990, 9 (05) : 1595 - 1602